Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice
Yunzeng Zou(Fudan University), Junbo Ge(Sun Yat-sen University), Jianming Wei(Jinshan Hospital of Fudan University), Jian Wu(Shanghai Medical College of Fudan University), Ning Zhou(Tongji Hospital), Lin Li(Kunming Medical University), Lei Li(Fudan University), Yong Ye(Unknown), Yunbo Li(Fuyang City People's Hospital), Hui Gong(Ningbo University), Jingmin Zhou(Tianjin Chest Hospital), Zhenhua Jia, Yanyan Liang(Anhui Medical University), Yiling Wu(Hebei Yiling Hospital)
Cited by 64
Related Papers
Somatic mutations of the mitochondrial genome in human colorectal tumours
|Nature Genetics|1998|839
Histone Lactylation Boosts Reparative Gene Activation Post–Myocardial Infarction
|Circulation Research|2022|532
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
|The Lancet Diabetes & Endocrinology|2017|325
Aggregation-induced phosphorescent emission (AIPE) of iridium(<scp>iii</scp>) complexes
|Chemical Communications|2007|283
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273